iaremenko-sergii-shutterstock-com-3d-printing-
Iaremenko Sergii / Shutterstock.com
5 January 2017AmericasArlene Chow and Nitya Anand

New technologies, old framework: maximising IP protection for 3D printing in the life sciences

3D printing technology has transformed the life sciences industry. It is already being used to make marketed medical devices and pharmaceutical products and, with some sources predicting overall 3D printing revenue as high as $21 billion worldwide by 2020, there can be no question that life sciences 3D printing will continue to grow in importance and scope.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
8 January 2026   Important questions about when companies must act on suspicions of theft and whether damages can stack with injunctions were raised in a dispute that has already sent ripples across med tech.
Americas
8 January 2026   Crop science division alleges that vaccine developers used patented mRNA stability technology in shots that earned them around $140 billion in global sales.
Americas
6 January 2026   The new recruits from a boutique Boston firm enables Merchant to expand and strengthen its tech and life sciences offering in the innovation hub.